Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Nasal potential difference in suspected cystic fibrosis patients with 5T polymorphism.

Aalbers BL, Yaakov Y, Derichs N, Simmonds NJ, De Wachter E, Melotti P, De Boeck K, Leal T, Tümmler B, Wilschanski M, Bronsveld I.

J Cyst Fibros. 2019 Jul 19. pii: S1569-1993(19)30822-7. doi: 10.1016/j.jcf.2019.07.001. [Epub ahead of print]

PMID:
31331863
2.

A model-based economic evaluation of four newborn screening strategies for cystic fibrosis in Flanders, Belgium.

Schmidt M, Werbrouck A, Verhaeghe N, De Wachter E, Simoens S, Annemans L, Putman K.

Acta Clin Belg. 2019 Apr 22:1-9. doi: 10.1080/17843286.2019.1604472. [Epub ahead of print]

PMID:
31007159
3.

Two CFTR mutations within codon 970 differently impact on the chloride channel functionality.

Amato F, Scudieri P, Musante I, Tomati V, Caci E, Comegna M, Maietta S, Manzoni F, Di Lullo AM, De Wachter E, Vanderhelst E, Terlizzi V, Braggion C, Castaldo G, Galietta LJV.

Hum Mutat. 2019 Jun;40(6):742-748. doi: 10.1002/humu.23741. Epub 2019 Mar 28.

PMID:
30851139
4.

Exhaled nitric oxide in stable adult cystic fibrosis patients, during exacerbation and following CFTR-modifying treatment.

Vincken S, Verbanck S, De Wachter E, Vanderhelst E.

Eur Respir J. 2019 May 30;53(5). pii: 1802259. doi: 10.1183/13993003.02259-2018. Print 2019 May. No abstract available.

PMID:
30819814
5.

Respiratory Bacterial Culture Sampling in Expectorating and Non-expectorating Patients With Cystic Fibrosis.

Eyns H, Piérard D, De Wachter E, Eeckhout L, Vaes P, Malfroot A.

Front Pediatr. 2018 Dec 18;6:403. doi: 10.3389/fped.2018.00403. eCollection 2018.

6.

Pulmonary function patterns and their association with genotype and phenotype in adult cystic fibrosis patients.

Stylemans D, Verbanck S, Vincken S, Vincken W, De Wachter E, Vanderhelst E.

Acta Clin Belg. 2018 Oct 12:1-7. doi: 10.1080/17843286.2018.1533716. [Epub ahead of print]

PMID:
30311545
7.

In Vitro Susceptibility of Burkholderia cepacia Complex Isolated from Cystic Fibrosis Patients to Ceftazidime-Avibactam and Ceftolozane-Tazobactam.

Van Dalem A, Herpol M, Echahidi F, Peeters C, Wybo I, De Wachter E, Vandamme P, Piérard D.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00590-18. doi: 10.1128/AAC.00590-18. Print 2018 Sep.

8.

Strategies for newborn screening for cystic fibrosis: A systematic review of health economic evaluations.

Schmidt M, Werbrouck A, Verhaeghe N, De Wachter E, Simoens S, Annemans L, Putman K.

J Cyst Fibros. 2018 May;17(3):306-315. doi: 10.1016/j.jcf.2018.03.002. Epub 2018 Mar 20. Review.

PMID:
29572018
9.

Acute Pain Perception During Different Sampling Methods for Respiratory Culture in Cystic Fibrosis Patients.

Eyns H, De Wachter E, Malfroot A, Vaes P.

J Pain Symptom Manage. 2018 Mar;55(3):872-880. doi: 10.1016/j.jpainsymman.2017.11.004. Epub 2017 Nov 14.

PMID:
29154891
10.

What can the CF registry tell us about rare CFTR-mutations? A Belgian study.

De Wachter E, Thomas M, Wanyama SS, Seneca S, Malfroot A.

Orphanet J Rare Dis. 2017 Aug 22;12(1):142. doi: 10.1186/s13023-017-0694-1.

11.

Gastric emptying and gastro-oesophageal reflux in children with cystic fibrosis.

Hauser B, De Schepper J, Malfroot A, De Wachter E, De Schutter I, Keymolen K, Vandenplas Y.

J Cyst Fibros. 2016 Jul;15(4):540-7. doi: 10.1016/j.jcf.2015.12.015. Epub 2016 Jan 8.

12.

A semi-blinded study comparing 2 methods of measuring nasal potential difference: Subcutaneous needle versus dermal abrasion.

De Wachter E, De Schutter I, Meulemans A, Buyl R, Malfroot A.

J Cyst Fibros. 2016 Jan;15(1):60-6. doi: 10.1016/j.jcf.2015.06.007. Epub 2015 Jul 16.

13.

Quantitative bone ultrasound at the distal radius in adults with cystic fibrosis.

Roggen I, Louis O, Van Biervliet S, Van Daele S, Robberecht E, De Wachter E, Malfroot A, De Waele K, Gies I, Vanbesien J, De Schepper J.

Ultrasound Med Biol. 2015 Jan;41(1):334-8. doi: 10.1016/j.ultrasmedbio.2014.08.003. Epub 2014 Oct 22.

PMID:
25438860
14.

Increase in ventilated air spaces after eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients.

Vanderhelst E, De Wachter E, Willekens J, Schuermans D, Vincken W, Malfroot A, Verbanck S.

Acta Clin Belg. 2015 Feb;70(1):30-3. doi: 10.1179/2295333714Y.0000000079. Epub 2014 Sep 24.

PMID:
25253536
15.

Pulmonary disease in cystic fibrosis: assessment with chest CT at chest radiography dose levels.

Ernst CW, Basten IA, Ilsen B, Buls N, Van Gompel G, De Wachter E, Nieboer KH, Verhelle F, Malfroot A, Coomans D, De Maeseneer M, de Mey J.

Radiology. 2014 Nov;273(2):597-605. doi: 10.1148/radiol.14132201. Epub 2014 Jul 25.

PMID:
25057981
16.

Nutritional status of children hospitalized for parapneumonic effusion.

Huysentruyt K, Alliet P, Raes M, Willekens J, De Schutter I, De Wachter E, Malfroot A, Devreker T, Goyens P, Vandenplas Y, De Schepper J.

PLoS One. 2014 Apr 4;9(4):e94242. doi: 10.1371/journal.pone.0094242. eCollection 2014.

17.

Eradication of chronic methicillin-resistant Staphylococcus aureus infection in cystic fibrosis patients. An observational prospective cohort study of 11 patients.

Vanderhelst E, De Wachter E, Willekens J, Piérard D, Vincken W, Malfroot A.

J Cyst Fibros. 2013 Dec;12(6):662-6. doi: 10.1016/j.jcf.2013.04.009. Epub 2013 May 21.

18.

CFTR biomarkers: time for promotion to surrogate end-point.

De Boeck K, Kent L, Davies J, Derichs N, Amaral M, Rowe SM, Middleton P, de Jonge H, Bronsveld I, Wilschanski M, Melotti P, Danner-Boucher I, Boerner S, Fajac I, Southern K, de Nooijer RA, Bot A, de Rijke Y, de Wachter E, Leal T, Vermeulen F, Hug MJ, Rault G, Nguyen-Khoa T, Barreto C, Proesmans M, Sermet-Gaudelus I; European Cystic Fibrosis Society Clinical Trial Network Standardisation Committee.

Eur Respir J. 2013 Jan;41(1):203-16. doi: 10.1183/09031936.00057512. Epub 2012 Aug 9. Review.

19.

Comparative bone status assessment by dual energy X-ray absorptiometry, peripheral quantitative computed tomography and quantitative ultrasound in adolescents and young adults with cystic fibrosis.

De Schepper J, Roggen I, Van Biervliet S, Robberecht E, Gies I, De Waele K, De Wachter E, Malfroot A, De Baets F, Toye K, Goemaere S, Louis O.

J Cyst Fibros. 2012 Mar;11(2):119-24. doi: 10.1016/j.jcf.2011.10.004. Epub 2011 Nov 26.

20.

Malacia, inflammation and bronchoalveolar lavage culture in children with persistent respiratory symptoms.

De Baets F, De Schutter I, Aarts C, Haerynck F, Van Daele S, De Wachter E, Malfroot A, Schelstraete P.

Eur Respir J. 2012 Feb;39(2):392-5. doi: 10.1183/09031936.00035111. Epub 2011 Jul 20.

21.

Microbiology of bronchoalveolar lavage fluid in children with acute nonresponding or recurrent community-acquired pneumonia: identification of nontypeable Haemophilus influenzae as a major pathogen.

De Schutter I, De Wachter E, Crokaert F, Verhaegen J, Soetens O, Piérard D, Malfroot A.

Clin Infect Dis. 2011 Jun 15;52(12):1437-44. doi: 10.1093/cid/cir235.

PMID:
21628484
22.

The relationship between gastroesophageal reflux and cough in children with chronic unexplained cough using combined impedance-pH-manometry recordings.

Blondeau K, Mertens V, Dupont L, Pauwels A, Farré R, Malfroot A, De Wachter E, De Schutter I, Hauser B, Vandenplas Y, Sifrim D.

Pediatr Pulmonol. 2011 Mar;46(3):286-94. doi: 10.1002/ppul.21365. Epub 2010 Oct 22.

PMID:
20967945
23.

Comparison of culture and qPCR for the detection of Pseudomonas aeruginosa in not chronically infected cystic fibrosis patients.

Deschaght P, Schelstraete P, Lopes dos Santos Santiago G, Van Simaey L, Haerynck F, Van Daele S, De Wachter E, Malfroot A, Lebecque P, Knoop C, Casimir G, Boboli H, Pierart F, Desager K, Vaneechoutte M, De Baets F.

BMC Microbiol. 2010 Sep 24;10:245. doi: 10.1186/1471-2180-10-245.

24.

Milk protein and Oil-Red-O staining of alveolar macrophages in chronic respiratory disease of infancy.

De Baets F, Aarts C, Van Daele S, Haerynck F, De Wachter E, De Schutter I, Malfroot A, Schelstraete P.

Pediatr Pulmonol. 2010 Dec;45(12):1213-9. doi: 10.1002/ppul.21310. Epub 2010 Aug 17.

PMID:
20717909
25.

Characteristics of gastroesophageal reflux and potential risk of gastric content aspiration in children with cystic fibrosis.

Blondeau K, Pauwels A, Dupont Lj, Mertens V, Proesmans M, Orel R, Brecelj J, López-Alonso M, Moya M, Malfroot A, De Wachter E, Vandenplas Y, Hauser B, Sifrim D.

J Pediatr Gastroenterol Nutr. 2010 Feb;50(2):161-6. doi: 10.1097/MPG.0b013e3181acae98.

PMID:
19966579
26.

Well-nourished cystic fibrosis patients have normal mineral density, but reduced cortical thickness at the forearm.

Louis O, Clerinx P, Gies I, De Wachter E, De Schepper J.

Osteoporos Int. 2009 Feb;20(2):309-14. doi: 10.1007/s00198-008-0646-7. Epub 2008 Jun 7.

PMID:
18536951
27.

Isolated tracheoesophageal fistula in a 10-year-old girl.

De Schutter I, Vermeulen F, De Wachter E, Ernst C, Malfroot A.

Eur J Pediatr. 2007 Sep;166(9):911-4. Epub 2006 Nov 21.

PMID:
17120034
28.

Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450.

De Wachter E, Malfroot A, De Schutter I, Vanbesien J, De Schepper J.

J Cyst Fibros. 2003 Jun;2(2):72-5.

29.

Rapidly developing Cushing syndrome in a 4-year-old patient during combined treatment with itraconazole and inhaled budesonide.

De Wachter E, Vanbesien J, De Schutter I, Malfroot A, De Schepper J.

Eur J Pediatr. 2003 Jul;162(7-8):488-489. doi: 10.1007/s00431-003-1233-8. Epub 2003 Apr 26.

PMID:
12719971

Supplemental Content

Loading ...
Support Center